COMTAN 200 MG
ENTACAPONE : 200 MG · DIN 02243763 · SANDOZ CANADA INCORPORATED
Health Canada status: DORMANT
What is COMTAN?
COMTAN 200 MG contains ENTACAPONE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02243763, held by SANDOZ CANADA INCORPORATED, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 08-Sep-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is COMTAN used for?
COMTAN* (entacapone) is indicated as an adjunct to levodopa/carbidopa or levodopa/benserazide preparations to treat patients with idiopathic Parkinson’s Disease who experience the signs and symptoms of end-of-dose “wearing-off”.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02243763 |
|---|---|
| Brand name | COMTAN |
| Generic / active ingredient | ENTACAPONE : 200 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N04BX02 ENTACAPONE |
| AHFS class | 28:36.12 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 08-Sep-2023 |
| Original market date | 2001-06-21 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02243763 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2243763 |
| Brand name | COMTAN |
| Active ingredient / INN | ENTACAPONE : 200 MG |
| ATC code | N04BX02 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N04 |
| AHFS class | 28:36.12 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | SANDOZ CANADA INCORPORATED |
How is it stored and handled?
null
How is it supplied?
null
Which pack is which?
| Strength on the label | 200 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Packaging as described in the monograph | null |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code N04BX02 ENTACAPONE. 3 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MINT-ENTACAPONE | 200 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02535939 |
| SANDOZ ENTACAPONE | 200 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02380005 |
| TEVA-ENTACAPONE | 200 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02375559 |
| APO-ENTACAPONE | 200 MG | TABLET | APOTEX INC | APPROVED | DIN 02321459 |
| AURO-ENTACAPONE | 200 MG | TABLET | AURO PHARMA INC | APPROVED | DIN 02431602 |
| MYLAN-ENTACAPONE | 200 MG | TABLET | MYLAN PHARMACEUTICALS ULC | CANCELLED POST MARKET | DIN 02390337 |
Who else supplies ENTACAPONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ENTACAPONE appears in 20 registered pack listings across 11 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does ENTACAPONE cost around the world?
ENTACAPONE is listed on 11 national price registers Nexara tracks, across 28 pack listings published on 10 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 1 | 11 | 03 Sep 2026 |
| Saudi Arabia | public | 5 | 5 | 01 Sep 2026 |
| Australia | ex-manufacturer | 1 | 2 | 08 Sep 2026 |
| United Kingdom | hospital | 2 | 2 | 31 Aug 2026 |
| South Africa | single exit price | 2 | 2 | 01 Sep 2026 |
| Austria | KVP (Kassenverkaufspreis) | 1 | 1 | 03 Sep 2026 |
| Czechia | max producer price (ex-factory) | 1 | 1 | 03 Sep 2026 |
| Greece | producer price (ex-factory) | 1 | 1 | 03 Sep 2026 |
| Hungary | producer price (ex-factory) | 1 | 1 | 03 Sep 2026 |
| Italy | prezzo al pubblico (classe A) | 1 | 1 | 02 Sep 2026 |
| Luxembourg | reimbursement | 1 | 1 | 05 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.